Ginsenoside F4

SKU: orb1684961

Description

Ginsenoside F4

Research Area

Cell Biology, Immunology & Inflammation, Protein Biochemistry

Key Properties

• CAS Number: 181225-33-2
• MW: 767.01
• Purity: 97.34% (May vary between batches)
• Formula: C₄₂H₇₀O₁₂
• SMILES: C[C@]12[C@@]3(C)[C@@]([C@@H](\C(=C\CC=C(C)C)\C)CC3)([C@H](O)C[C@@]1([C@]4(C)[C@@]([C@@H](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O)[C@@H](CO)O5)C2)(C(C)(C)[C@@H](O)CC4)[H])[H])[H]
• Target: Apoptosis,MMP,IL Receptor,Bcl-2 Family
• Solubility: 10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (1.3 mM);DMSO:40 mg/mL (52.15 mM)

Bioactivity

• In Vitro:
  Methods: Ginsenoside F4 (8.15 μM, 65.19 μM, 130.38 μM) was used to treat Homo sapiens lymphoblastoma JK cells, and the expression of related proteins was detected by Western Blot. Results: Ginsenoside F4 induced apoptosis in Homo sapiens lymphoblastoma JK cells by downregulating Bcl-2 protein and upregulating Bax protein levels, which are key regulators associated with apoptosis, demonstrating its antitumor effects.
  Read more...

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

Ginsenoside F-4

Compound Identifiers

PubChem CID

102179726